SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Other Working Capital

Cash effect of changes in other operating assets and liabilities.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Other Working Capital · Q1 FY2026 · quarter ended Mar 2026

Other working capital of -$2.48M in Q1 FY2026

Q1 FY2026 other working capital was -$2.48M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.48M-259.7% QoQ
Last fiscal yearDec 2025
$1.91M— YoY
Other Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Working Capital history

USD · from the cash flow

Latest · FY2025
1.91M USD
Year-over-year change
—

Other Working Capital vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so other working capital is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Other Working Capital for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$272.74M USD+494.9%-8.6%2.5%
STAASTAAR Surgical CompanyLTM Apr 2026$37.07M USD-217.9%+85.6%12.8%
GKOSGlaukos CorporationLTM Jun 2026$23.49M USD+844.3%—3.8%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$8.59M USD-62.7%+228.3%112.8%
BLCOBausch + Lomb CorporationLTM Jun 2026$7.26M USD-39.5%—0.1%
RXSTRxSight, Inc.LTM Mar 2026$4.08M USD+115.1%—3.2%
SGHTSight Sciences, Inc.LTM Mar 2026$2.22M USD+130.2%—2.8%
SGPSpyGlass Pharma, Inc. Common StockFY2025$1.91M USD———
OCSOculis Holding AGLTM Mar 2026CHF 1.53M CHF-81.9%—303.8%
OCULOcular Therapeutix, Inc.LTM Mar 2026$90K USD-100.9%+36.8%0.2%
Peer median (excluding SGP) —-39.5%+61.2%3.2%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.